We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Oral Abstracts.
- Abstract
Blood cancer is often overlooked but is a significant cause of death in the UK. Lack of awareness and disparities in access to information and support are major issues. Avapritinib, a KIT D816V inhibitor, shows promise as a treatment for advanced systemic mastocytosis. Various studies in hematology and transfusion medicine explore topics such as immunomodulatory role of eltrombopag, JAK2 variant allele burden, cerebral microbleeds, plasma cell neoplasms, ABO matching for platelet transfusions, and electronic transfusion systems. Studies on lymphoma treatment discuss the use of glofitamab, epcoritamab, brentuximab vedotin, and bendamustine. Other studies cover topics like prophylactic platelet transfusion, transfusion-associated circulatory overload risk assessments, nivolumab for relapsed classical Hodgkin lymphoma, and patient journey maps for sickle cell disorder. Additional studies examine critical illness, extracorporeal membrane oxygenation, emicizumab for severe hemophilia A, rivaroxaban for cerebral venous sinus thrombosis, and CAR-T cell therapy outcomes. Studies related to hematological diseases and treatments cover topics like CMV reactivation, BEAM autologous transplantation, obe-cel for B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic cell transplantation for myelofibrosis. Leukemia studies
- Subjects
BLOOD transfusion reaction; MAST cell disease; PATIENTS' attitudes; CLINICAL decision support systems; BISPECIFIC antibodies; COMPLEMENT (Immunology)
- Publication
British Journal of Haematology, 2024, Vol 204, p4
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/bjh.19397